Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Ann Endocrinol (Paris) ; 84(3): 364-366, 2023 May.
Article in English | MEDLINE | ID: mdl-36965853

ABSTRACT

Factitious hypoglycemia is a factitious disorder according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), referring to intentionally covertly induced hypoglycemia, with potentially severe consequences. Knowledge of factitious hypoglycemia relies on case reports, and evidence-based information and guidelines are lacking. Diagnosing factitious hypoglycemia in insulin-treated diabetic persons is therefore challenging and often requires a long and costly process. Moreover, the typical metrics proposed to differentiate insulin-induced factitious hypoglycemia from insulinoma (i.e., high insulin and low C-peptide versus high insulin and high C-peptide, respectively) are not always applicable, depending on whether the insulin quantification method can detect the insulin analog. When factitious hypoglycemia is suspected, an emerging trend from recent publications advocates a combination of two insulin quantification methods with different cross-reactivity for insulin analogs, early on in the diagnostic process.


Subject(s)
Diabetes Mellitus , Factitious Disorders , Hypoglycemia , Pancreatic Neoplasms , Humans , Insulin/adverse effects , C-Peptide/adverse effects , Hypoglycemia/chemically induced , Hypoglycemia/diagnosis , Factitious Disorders/diagnosis , Factitious Disorders/chemically induced , Factitious Disorders/complications , Pancreatic Neoplasms/complications , Diabetes Mellitus/drug therapy , Diabetes Mellitus/chemically induced
2.
Pediatr Diabetes ; 19(4): 823-831, 2018 06.
Article in English | MEDLINE | ID: mdl-29464887

ABSTRACT

BACKGROUND: Factitious hypoglycemia is a condition of self-induced hypoglycemia due to surreptitious administration of insulin or oral hypoglycemic agents. In adults, it is an uncommon, but well known clinical entity observed in individuals with and without diabetes. OBJECTIVES: To report a case of factitious hypoglycemia highlighting diagnostic pitfalls, to identify common characteristics of children and adolescents with factitious hypoglycemia, and to examine whether the information on long-term outcome exists. METHODS: We present a case of an adolescent with type 1 diabetes who had self-induced hypoglycemia of several years' duration; and we conducted a systematic literature review on factitious hypoglycemia in pediatric patients with diabetes. RESULTS: We identified a total of 83 articles of which 14 met the inclusion criteria (describing 39 cases). All but 1 individual had type 1 diabetes and the majority was female (63%). Average age was 13.5 ± 2.0 years with the youngest patient presenting at the age 9.5 years. Blood glucose control was poor (hemoglobin A1c: 12.1 ± 4.0%). In 35%, psychiatric disorders were mentioned as contributing factors. Only 3 reports provided follow-up beyond 6 months. CONCLUSIONS: Factitious hypoglycemia typically occurs in adolescents with type 1 diabetes who use insulin to induce hypoglycemia. Awareness of this differential diagnosis and knowledge of potentially misleading laboratory results may facilitate earlier recognition and intervention. Little information exists on effective treatments and long-term outcome.


Subject(s)
Diabetes Mellitus, Type 1/diagnosis , Factitious Disorders/chemically induced , Factitious Disorders/diagnosis , Hypoglycemia/chemically induced , Insulin/adverse effects , Adolescent , Blood Glucose/drug effects , Blood Glucose/metabolism , Diabetes Mellitus, Type 1/blood , Diagnosis, Differential , Female , Humans , Hypoglycemia/diagnosis , Insulin/administration & dosage
4.
Arch Clin Neuropsychol ; 29(7): 715-23, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25280796

ABSTRACT

Very few data are available on the long-term changes in the cognitive abilities of patients with loss of psychic self-activation syndrome (LPSAS). Here, we present a 25-year follow-up study on a case of LPSAS resulting from bilateral pallidal lesions caused by carbon monoxide intoxication. Typical signs of LPSAS were observed, showing no changes in severity, but Ganser syndrome (GS) gradually developed and worsened during the follow-up period. GS is generally assumed to be a psychogenic syndrome, but an organic etiology has been suspected by the authors of several case reports. Here, atypical features of GS plead against the independence of GS and LPSAS. DaTSCAN and brain 18FDG-PET were performed. Since left hippocampal hypometabolism has been previously described in patients with functional amnesia, it is possible that long periods of mental inactivity may have psychological consequences, but the atypical features of GS also suggest that an organic mechanism may be involved.


Subject(s)
Akinetic Mutism , Carbon Monoxide Poisoning/complications , Factitious Disorders , Adult , Akinetic Mutism/chemically induced , Akinetic Mutism/diagnosis , Akinetic Mutism/physiopathology , Brain/metabolism , Brain/pathology , Brain/physiopathology , Factitious Disorders/chemically induced , Factitious Disorders/diagnosis , Factitious Disorders/etiology , Female , Follow-Up Studies , Humans
6.
Ann Biol Clin (Paris) ; 70(3): 335-40, 2012.
Article in French | MEDLINE | ID: mdl-22565183

ABSTRACT

A 44 years-old diabetic male patient was admitted several times to the emergency department of Albi Hospital (France) for nocturnal hypoglycemias with losses of consciousness. The initial blood analysis, performed on a Cobas(®) analyzer, retrieved low levels of insulinemia. This patient was treated by analogues of insulin and did not present any comorbidities. Moreover, an extensive check-up did not retrieve any evident cause for these hypoglycemias. After a severe hypoglycemic coma that occurred during the last hospitalization when insulinotherapy was interrupted, the staff suggested the possibility of a factice hypoglycemia by surreptitious administration of insulin. Hormonal assays were then performed on a Centaur(®) analyzer, which is able to recognize insulin aspart and glargine. They revealed elevated concentrations of insulin along with low levels of C-peptide. Such a blood profile is consistent with an exogenous administration of insulin or its analogues. On the basis of this biological clue, the patient was questioned again and he finally admitted self-injection of insulin aspart. This case gives us the opportunity to review the diabetic hypoglycemia, to point out the particularities of the blood assays of insulin analogues and to confirm the need of a close collaboration between clinic and laboratory staffs in the difficult cases of factice hypoglycemias.


Subject(s)
Diabetes Mellitus/drug therapy , Hypoglycemia/chemically induced , Insulin/administration & dosage , Adult , Amino Acid Sequence , Factitious Disorders/chemically induced , Factitious Disorders/diagnosis , Humans , Hypoglycemia/diagnosis , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/adverse effects , Insulin/adverse effects , Insulin/analogs & derivatives , Insulin/chemistry , Insulin Aspart/administration & dosage , Insulin Aspart/adverse effects , Insulin Aspart/chemistry , Male , Self Administration , Severity of Illness Index
9.
Hautarzt ; 59(7): 571-5, 2008 Jul.
Article in German | MEDLINE | ID: mdl-17924082

ABSTRACT

A 68-year-old woman with insulin-dependent diabetes mellitus presented with blue nodules on the ventral aspect of the thorax. According to the past history, these lesions had developed repeatedly. She had already had bilateral mastectomies and lymph node dissection. The histologic diagnosis was always mastitis with plasma cells and no neoplasia. Yet another biopsy was taken; the subcutis was stained blue-black. Histology revealed exogenous black pigment and mastitis. With Raman spectroscopy the pigment was identified as carbon black, which is a component of India ink. These findings together with the unusual course of the disease suggested the diagnosis of an artificial disorder. The likely conclusion is that our patient, over years, used her own (insulin) syringe to inject India ink into her skin and subcutaneous tissue; the damaging effect and tissue reaction was probably caused by preservatives such as phenol.


Subject(s)
Carbon/adverse effects , Factitious Disorders/chemically induced , Granuloma, Foreign-Body/chemically induced , Injections, Subcutaneous/adverse effects , Aged , Breast Neoplasms/radiotherapy , Breast Neoplasms/surgery , Carbon/administration & dosage , Diagnosis, Differential , Factitious Disorders/pathology , Female , Granuloma, Foreign-Body/pathology , Humans , Lymph Nodes/surgery , Lymphatic Metastasis , Neoplasm Recurrence, Local/prevention & control
10.
Clin Chem ; 53(1): 85-90, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17110471

ABSTRACT

BACKGROUND: Surreptitious ingestion of laxatives can lead to serious factitious diseases that are difficult to diagnose. Most cases involve ingestion of bisacodyl or senna. Thin layer chromatography (TLC) of urine or stool is the only commercially available test for these laxatives. Such testing is considered highly reliable, but its accuracy in clinical practice is unknown. Our aim was to evaluate the reliability of TLC laxative testing by a clinical reference laboratory in the United States. METHODS: Diarrhea was induced in healthy volunteers by ingestion of bisacodyl, senna, or a control laxative (n = 11 for each laxative group). Samples of urine and diarrheal stool were sent in blinded fashion to the clinical reference laboratory for bisacodyl and senna analysis. RESULTS: TLC testing for bisacodyl-induced diarrhea revealed a sensitivity of 73% and specificity of 91% when urine was tested and sensitivity and specificity of 91% and 96%, respectively, when stool was analyzed. When diarrhea was induced by senna, the TLC assay for senna failed to identify even a single urine or stool specimen as positive (zero% sensitivity). CONCLUSIONS: Considering the expected prevalence of surreptitious laxative abuse in patients with chronic idiopathic diarrhea (2.4%-25%, depending on the clinical setting), TLC of urine or stool for bisacodyl by this reference laboratory would often produce misleading results, and testing for senna would have no clinical value. The major problems are false-positive tests for bisacodyl and false-negative tests for senna.


Subject(s)
Cathartics/adverse effects , Cathartics/analysis , Clinical Laboratory Techniques/standards , Diarrhea/diagnosis , Factitious Disorders/diagnosis , Bisacodyl/adverse effects , Bisacodyl/analysis , Bisacodyl/urine , Chromatography, Thin Layer , Diarrhea/chemically induced , Factitious Disorders/chemically induced , False Negative Reactions , False Positive Reactions , Feces/chemistry , Humans , Laboratories/standards , Likelihood Functions , Reference Standards , Senna Extract/adverse effects , Senna Extract/analysis , Senna Extract/urine , Sensitivity and Specificity
11.
Endocr Pract ; 12(5): 568-71, 2006.
Article in English | MEDLINE | ID: mdl-17002933

ABSTRACT

OBJECTIVE: To report a case of epinephrine-induced factitious pheochromocytoma in a young woman with a past medical history of Conn's syndrome. METHODS: We present a case report with clinical and laboratory details, review related reports in the literature, and demonstrate the usefulness of plasma free metanephrine levels in facilitating the diagnosis of factitious pheochromocytoma. RESULTS: A 34-year-old woman was admitted to our hospital for confirmation and localization of an occult pheochromocytoma. After thorough investigation, we discovered that the patient was surreptitiously injecting epinephrine in order to induce symptoms and signs consistent with a pheochromocytoma. Analysis of the patient's biochemical profile during and between her catecholaminergic crises revealed plasma epinephrine and free metanephrine levels that would be highly unusual for a patient with a pheochromocytoma. CONCLUSION: This case illustrates the utility of implementing the ratio of plasma epinephrine to free metanephrine levels in distinguishing factitious from organic pheochromocytoma.


Subject(s)
Factitious Disorders/chemically induced , Metanephrine/blood , Pheochromocytoma/diagnosis , Adult , Diagnosis, Differential , Epinephrine/administration & dosage , Epinephrine/urine , Factitious Disorders/blood , Female , Humans , Metanephrine/urine , Norepinephrine/blood , Normetanephrine/blood , Pheochromocytoma/blood
12.
Endocr Pract ; 12(6): 651-5, 2006.
Article in English | MEDLINE | ID: mdl-17229661

ABSTRACT

OBJECTIVE: To present the first reported fatality from invasive aspergillosis related to factitious Cushing's syndrome. METHODS: We summarize the history, clinical findings, and outcome in a patient ultimately found to have factitious Cushing's syndrome. In addition, the dangers of fulminant infections in untreated Cushing's syndrome are analyzed relative to molecular and immunologic aspects, and the pertinent literature is reviewed. RESULTS: A 33-year-old female medical transcriptionist was admitted with rapidly fatal septic shock and diffuse pulmonary infiltrates. Autopsy revealed invasive pulmonary aspergillosis and atrophied adrenal cortices. On subsequent investigation, hidden bottles of prednisone were found throughout the patient's home. Factitious Cushing's syndrome has rarely been described and can be a difficult diagnosis to establish, but it is important to recognize this condition because of its potentially drastic consequences. Our understanding of the mechanism of immunosuppression from glucocorticoids related to the increased risk of invasive fungal infections is evolving. Factitious illness can manifest in numerous ways; therefore, health-care providers in all specialties should be familiar with epidemiologic, diagnostic, and treatment considerations for this illness. CONCLUSION: Endocrinologists should be aware of the possibility of factitious Cushing's syndrome because it can be an elusive and ultimately fatal condition.


Subject(s)
Aspergillosis/etiology , Cushing Syndrome/complications , Cushing Syndrome/diagnosis , Factitious Disorders/complications , Factitious Disorders/diagnosis , Adult , Cushing Syndrome/chemically induced , Factitious Disorders/chemically induced , Fatal Outcome , Female , Glucocorticoids/poisoning , Humans , Lung Diseases, Fungal/complications , Prednisone/poisoning
14.
Ann Pharmacother ; 37(1): 80-2, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12503939

ABSTRACT

OBJECTIVE: To report a case of dementing syndrome resulting from ibuprofen use. CASE SUMMARY: A 76-year-old white man with normal mental status became confused, was lost in familiar places, and showed short-term memory loss after beginning a therapeutic regimen of ibuprofen 600 mg 3 times daily for osteoarthritis in anticipation of embarking on a foreign trip. Symptoms of dementia began within 1 week after taking ibuprofen and resolved completely within 1 week after the ibuprofen regimen was stopped. This pattern was repeated 6 months later, when the patient again traveled abroad. Consistently before, during, and after these events, the patient took atenolol, clonidine, lisinopril, aspirin, vitamin C, lecithin, vitamin E, and multivitamins. DISCUSSION: Using the Naranjo probability scale, we reasoned that the patient's dementia-like syndrome could be attributed to the use of ibuprofen because pseudodementia appeared after the suspected drug was administered, improved when the drug was discontinued, reappeared when the drug was readministered, had no apparent alternative cause, manifested similarly after each exposure to ibuprofen, and was confirmed by the family's observation after both episodes. Objective causality assessment revealed that the adverse drug reaction was probable. CONCLUSIONS: Use of ibuprofen must be considered during clinical evaluation of any patient with new onset of dementing illness. The Naranjo probability scale may be clinically useful for evaluating other pharmaceutical agents that may be contributing to development of dementia-like conditions.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Factitious Disorders/chemically induced , Ibuprofen/adverse effects , Aged , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Humans , Ibuprofen/therapeutic use , Male , Osteoarthritis/drug therapy
17.
Int J Dermatol ; 40(12): 743-6, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11903666

ABSTRACT

BACKGROUND: Factitious disease involving the breast is unusual. The rarely reported cases of this entity have been encountered in middle-aged women. In general, factitious disease can be distinguished on clinical and/or psychological grounds from self-induced disorders seen in malingerers and among those demonstrating Munchausen's syndrome. METHODS: We report herein a male patient displaying factitious disease of the breast due to injection of a high viscosity liquid plastic material. RESULTS: Establishment of the proper diagnosis was greatly delayed due to a lack of suspicion of this entity. Only direct confrontation of the patient with the biopsy results (lipogranulomatosis) led to a reluctant and then only partial admission of the self-induced nature of this patient's illness. CONCLUSION: The clinician should remain vigilant for factitious disease when confronted with chronic or recurrent lesions of a bizarre or atypical morphology. Any body site can be involved, including the breast. Management is difficult and is best accomplished in conjunction with an appropriate mental health professional. Continued dramatic surgical interventions are contraindicated.


Subject(s)
Breast Diseases/chemically induced , Factitious Disorders/chemically induced , Self-Injurious Behavior/complications , Adult , Humans , Injections , Male , Plastics
18.
Endocrinol Metab Clin North Am ; 28(3): 579-601, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10500932

ABSTRACT

Factitious diseases are characterized by physical or psychologic symptoms that are voluntarily self-induced. These diseases are as old as mankind. Once called "malingerers," these patients must be distinguished from hysterics in whom symptoms are produced unconsciously. In factitious diseases, illness is produced by deliberate acts by the patient who when seeking medical help omits to mention them and may continue strenuously to deny them even when confronted with the evidence. Factitious diseases occur in patients who simulate or exaggerate symptoms or disability to obtain some kind of discernible personal gain or avoid an unpleasant situation; however, such actions may only produce disadvantages by exposing the patient to the risk of death or permanent injury. This has been described as Munchausen syndrome, which is probably a manifestation of severe psychiatric disease. The use of medicines or poisons to induce illness in others also produces a type of factitial disease and presents similar or greater difficulties in diagnosis. In both situations, the clinical history, ordinarily the most important clue to the correct diagnosis, is not only incomplete but often misleading. Sometimes referred to as Munchausen by proxy, this form of factitial disease may be impossible to distinguish from attempted murder or grievous bodily harm. The subtle differences between these disorders, if any, have not been discussed herein.


Subject(s)
Factitious Disorders , Forensic Medicine , Homicide , Hypoglycemia , Hypoglycemic Agents/administration & dosage , Suicide , Factitious Disorders/chemically induced , Factitious Disorders/diagnosis , Factitious Disorders/therapy , Humans , Hypoglycemia/chemically induced , Hypoglycemia/diagnosis , Hypoglycemia/therapy , Insulin/administration & dosage , Suicide, Attempted , Sulfonylurea Compounds/administration & dosage
19.
J Endocrinol Invest ; 22(2): 128-33, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10195380

ABSTRACT

Thyrotoxicosis factitia, a syndrome due to the surreptitious ingestion of excess thyroid hormones, has generally been diagnosed in young or middle-aged women with psychopathological disturbances. We reviewed all the cases seen at our Institution over a 24-yr period, from 1973 to 1996. All 25 patients were women. Analysis was restricted to 17 patients who were born and lived in Tuscany (our region), since only these patients were distributed during the whole observation period. Diagnosis of thyrotoxicosis factitia was based on the following parameters: elevated serum total and/or free thyroid hormone levels, undetectable serum thyrotropin levels, low/undetectable serum thyroglobulin concentration, normal urinary iodine excretion, low/suppressed thyroidal radioactive iodine uptake (RAIU), absence of goiter, absence of circulating anti-thyroid antibodies. Surreptitious ingestion of thyroid hormone pill was eventually admitted by all patients. Age at diagnosis was >50 yr in 7/17 patients (41%): 6 of them were distributed in the period 1995-1996, and one in 1988. Patients older than 60 yr were 5/17 (29%), all in the last two years of the period under investigation. There was an increase in the age of patients with thyrotoxicosis factitia (p=0.02), which lost a statistical significance when the patients of the 1995-1996 period were excluded from analysis (p=0.88). This study provides evidence of an increased age of patients with thyrotoxicosis factitia in more recent years. From a practical standpoint, our study suggests that thyrotoxicosis factitia should be suspected and adequately looked for even in old patients with thyrotoxicosis of inexplicable origin, especially in the absence of goiter and thyroid autoimmune phenomena, and when common causes of low-RAIU hyperthyroidism, such as a load with iodine-containing drugs or subacute thyroiditis, have been excluded.


Subject(s)
Age Factors , Factitious Disorders/epidemiology , Mental Disorders , Thyroid Hormones/poisoning , Thyrotoxicosis/epidemiology , Adolescent , Adult , Aged , Factitious Disorders/chemically induced , Factitious Disorders/psychology , Female , Humans , Iodine/urine , Iodine Radioisotopes , Italy/epidemiology , Middle Aged , Thyroglobulin/blood , Thyroid Hormones/blood , Thyrotoxicosis/chemically induced , Thyrotoxicosis/psychology , Thyrotropin/blood
20.
Diabet Med ; 12(5): 433-5, 1995 May.
Article in English | MEDLINE | ID: mdl-7648808

ABSTRACT

Two cases of factitious hypoglycaemia due to intentional or inadvertent intake of glipizide by non-diabetic subjects were identified through the measurement of this sulphonylurea in plasma by a modified assay procedure.


Subject(s)
Factitious Disorders/chemically induced , Glipizide/adverse effects , Hypoglycemia/chemically induced , Adult , Female , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...